User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 2 results.
    • Journal article
    Therapeutic value of clofarabine in younger and middle aged (18 - 65 yrs) adults with newly diagnosed AML.
    Löwenberg, Bob Pabst, Thomas Maertens, Johan van Norden, Yvette Biemond, Bart J Schouten, Harry C Spertini, Olivier Vellenga, Edo Graux, Carlos[UCL] Havelange, Violaine[UCL] de Greef, Georgine E de Weerdt, Okke Legdeur, Marie-Cecile J C Kuball, Juergen van Marwijk Kooy, Marinus Gjertsen, Bjorn T Jongen-Lavrencic, Mojca van de Loosdrecht, Arjan A van Lammeren-Venema, Daniëlle Hodossy, Beata Breems, Dimitri A Chalandon, Yves Passweg, Jakob Valk, Peter J M Manz, Markus G Ossenkoppele, Gert J Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) Swiss Group for Clinical Cancer Research (SAKK) (2017) Blood — Vol. 129, no. 12, p. 1636-1645 (2017)
    • Journal article
    Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK).
    Ossenkoppele, Gert J Stussi, Georg Maertens, Johan van Montfort, Kees Biemond, Bart J Breems, Dimitri Ferrant, August[UCL] Graux, Carlos[UCL] de Greef, Georgine E Halkes, C J M Hoogendoorn, Mels Hollestein, Rene M Jongen-Lavrencic, Mojca Levin, Mark D van de Loosdrecht, Arjan A van Marwijk Kooij, Marinus van Norden, Yvette Pabst, Thomas Schouten, Harry C Vellenga, Edo Verhoef, Gregor E G de Weerdt, Okke Wijermans, Pierre Passweg, Jakob R Löwenberg, Bob (2012) Blood — Vol. 120, no. 24, p. 4706-4711 (2012)